Lixte Biotechnology Holdings Inc logo

LIXT

NASDAQ

Lixte Biotechnology Holdings Inc

Price unavailable — configure POLYGON_API_KEY

Key Statistics
Market Cap$26.54M
P/E RatioN/A
Div. Yield
EPS (TTM)-$1.26
52W High$6.26
52W Low$0.64
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees
Price Performance
1 Week-1.29%
3 Month-19.31%
1 Year+157.38%
FinancialsAnnual · QuiverQuant
Revenue$0
Assets$4.31M
Liabilities$313,858
Net Income$5.09M loss

About

Lixte Biotechnology Holdings, Inc. is a drug discovery company that uses biomarker technology to identify enzyme targets related to serious common diseases and designs novel compounds to attack those targets. The company is headquartered in East Setauket, New York.

WebullFree stocks

Advanced charting, extended hours trading, and free stock for new accounts.

Open Account
Analyze LIXT with professional charts— Free to start

Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.